Hospital-Treated Gram-Positive Infections – Epidemiology – Emerging Markets Data

All forecast data are available on the DRG Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.
DRG Epidemiology provides at least ten years of forecast data for the following hospital-treated infection patient populations:
Diagnosed HCAP events due to S.aureus
Diagnosed BSI events due to CoNS
Diagnosed BSI events due to S.aureus
Diagnosed BSI events due to Enterococccus spp.
Diagnosed BSI events due to other gram-positive
Diagnosed cIAI events due to S.aureus
Diagnosed cIAI events due to CoNS
… and many more (details available on request).
Note: Coverage may vary by country and region.

Table of contents

  • Hospital-Treated Gram-Positive Infections - Epidemiology - Emerging Markets Data
    • Introduction
      • Key Findings
        • Overview
          • Diagnosed UTI Events per 1,000 People of All Ages in 2016 and 2026
          • Relative Sizes of the Contributing Factors to the Trend in Diagnosed UTI Events in the Next Ten Years
      • Epidemiology Data
      • Methods
        • Diagnosed UTI Events
        • Diagnosed NP Events
        • Diagnosed BSI Events
        • Diagnosed cIAI Events
        • Diagnosed cSSSI Events
        • Diagnosed SSI Events
        • Hospital-Treated Gram-Positive Infections: Pathogen Distribution
      • Reference Materials
        • Literature Review
          • Studies Included in the Analysis of Hospital-Treated Infections
          • Studies Excluded from the Analysis of Hospital-Treated Infections
        • Risk/Protective Factors
          • Risk/Protective Factors for Hospital-Treated Infections
        • Bibliography